, Primaeva Medical, Inc. 510(k) Premarket Notification
| 4 . | .
510(k) Summary - K082391
This 510(k) summary of safety and effectiveness is submitted in accordance with
. _ the requirements of 21 CFR 807.92.
Submitter: Primaeva Medical, Inc.
- 4160 Hacienda Drive, Suite 100 o
Pleasanton, CA 94588 USA
. Telephone: (925) 621-6100
. Fax: (925) 621-6101
Contact Person: Bankim Mehta ,
President & CEO
: . Telephone: (925) 621-6110
Date Prepared: August 24, 2009
. Trade Name: Primaeva Medical Miratone System
Common Name: Electrosurgical unit and accessories /
Classification: Class Il per 21 CFR 878.4400 — Electrosurgical cutting and
/ coagulation device and accessories
Product Code: GEI
Predicate Devices: Primaeva Medical Finesse System — K072261
Primaeva Medical System — K080145
_ . . . . |
Device Description: The Primaeva Medical Miratone System is comprised of
: the following components: A reusable radiofrequency (RF)
generator with user interface; a reusable cooler controller;
CONFIDENTIAL 7

Page 29 ®
- ote : 2
, Primaeva Medical, Inc. §10(k) Premarket Notification
a reusable cooler handpiece/applicator; a reusable
. electrode insertion device/applicator; and a single patient

~ use, disposable electrode cartridge. RF energy is delivered
from the RF generator through the electrodes into the
target tissue. :

Intended Use: The Primaeva Medical Miratone System is intended for use
in dermatologic and general surgical procedures for

‘ electrocoagulation and hemostasis, and the percutaneous
treatment of facial wrinkles.

Technological The Primaeva Medical Miratone System with indications

Characteristics for the percutaneous treatment of facial wrinkles is

Comparison: identical to the predicate Primaeva Medical System noted

‘ above.

The Primaeva Medical Miratone System with indications for
the percutaneous treatment of facial wrinkles is considered
to be substantially equivalent in terms of the target

population, energy source, principles of operation, etc., to
the above noted predicate devices.

Performance Data: Non-clinical testing of the Primaeva Medical Miratone
System included visual and, mechanical inspection,
electrical and mechanical safety testing, functional

. performance testing, etc., in bench and/or animal testing.

. : Clinical performance testing demonstrated the Primaeva
Medical Miratone System to be safe and effective in the
percutaneous treatment of facial wrinkles.

Summary: In summary, the results of non-clinical mechanical,
electrical and functional bench and/or animal testing, and
clinical performance testing have demonstrated that the.
Primaeva Medical Miratone System meets established

. design specifications; functions as intended; and is
: considered to be substantially equivalent to the above
noted predicate devices.

. , - End of section 
4 CONFIDENTIAL

f m4 DEPARTMENT OF HEALTH & HUMAN SERVICES _
“ve . 10903 New Hampshire Avenue
. Document Mail Center - WO66-G609
Silver Spring, MD 20993-0002
Primaeva Medical, Inc. . ;
, % Mr. Brian Grigsby . SEP = 1 2009
Vice President, QA & RA oO
4160 Hacienda Drive, Suite 100
Pleasanton, California 94588 .
Re: K082391
Trade/Device Name: Primaeva Medical Miratone System
Regulation Number: 21 CFR 878.4400
Regulation Name: Electrosurgical cutting and coagulation device and accessories
Regulatory Class: Class II ~
Product Code: GEI
Dated: June 30, 2009
, Received: July 2, 2009
Dear Mr. Grigsby: :
We have reviewed your Section 510(k) premarket notification of intent to market the device a
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
' devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, ,
‘and Cosmetic Act (Act) that do not require approval of'a premarket approval application (PMA).
’ You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice; labeling, and prohibitions against misbranding and :
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it
may be subject to additional controls. Existing major regulations affecting your device can be
found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may :
publish further announcements concerning your device in the Federal Register. Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
. that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical
device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set .

Page 2 - Mr. Brian Grigsby
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1 050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
go to http://www.fda.gov/A boutFDA/CentersO ffices/CDRH/CDRHOffices/ucm 1 15809.htny for
the Center for Devices and Radiological Health’s (CDRH’s) Office of Compliance. Also, please
note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part
807.97). For questions regarding the reporting of adverse events under the MDR regulation (21
CFR Part 803), please go to http://www.fda.gov/edrh/mdr/ for the CDRH’s Office of
: Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the
Division of Small Manufacturers, International and Consumer Assistance at its toll-free number
(800) 638-2041 or (240) 276-3150 or at its Internet address
http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours, wy .
fh IT Ye
; kN. MelkerSon () of
Director
. Division of Surgical, Orthopedic
. and Restorative Devices
. Office of Device Evaluation /
: . Center for Devices and
Radiological Health .
Enclosure : . i

Primaeva Medical, Inc. . 510(k)} Premarket Notification
' Indications for Use
510(k) Number (if known): ._ K082391
. Device Name: Primaeva Medical Miratone System
Indications for Use: :
The Primaeva Medical Miratone System is indicated for use in dermatologic and
: general surgical procedures for electrocoagulation and hemostasis, and the
, percutaneous treatment of facial wrinkles.
‘ Prescription Use X__— . AND/OR Over-The-Counter Use
(Part 21 CFR 801 Subpart D) . (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
. 4
: (Division Sign-Offy
: : Division of Surgical, Ort .
and Restorative Devices hoped, .
510(k) Number Id pee 49 |
: ee
- Page 1of_1__
L End of section -_ :
| .
~ CONFIDENTIAL

